Biogen (BIIB) insider buying

Healthcare · Drug Manufacturers - General · Market cap $30.4B

7 open-market purchases of BIIB by Biogen's executives and directors since August 2025, worth $585 in total, from SEC Form 4 filings.

The most recent: Nicole Murphy bought $585 on February 12, 2026.

The biggest buyer over the period is Nicole Murphy: 1 purchase, $585.

By year

YearPurchasesValue
20265$585
20252$0

Biggest buyers

InsiderBuysValue
Nicole Murphy
1$585
Gilbert Ray Cisneros, Jr.
2$0
Ro Khanna
4$0

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Feb 12, 2026 Nicole Murphy
3$195.03$585 Form 4
Jan 30, 2026 Gilbert Ray Cisneros, Jr.
0$179.89— —
Jan 30, 2026 Gilbert Ray Cisneros, Jr.
0$179.89— —
Jan 29, 2026 Ro Khanna
0$176.18— —
Jan 29, 2026 Ro Khanna
0$176.18— —
Aug 26, 2025 Ro Khanna
0$136.72— —
Aug 26, 2025 Ro Khanna
0$136.72— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for BIIB.
Open BIIB in Investingly

Questions

Are Biogen insiders buying the stock?

7 open-market purchases of BIIB by Biogen's executives and directors since August 2025, worth $585 in total, from SEC Form 4 filings. The most recent: Nicole Murphy bought $585 on February 12, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Biogen's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.